Administration of Toll-like receptor 3 (TLR3) agonist poly(I:C) strengthened the abscopal effect during radiotherapy (RT) through ferroptosis, and combination of poly(I:C) and RT improved the clinical benefits of advanced HCC patients. This evidence concerns the gene TLR3 and hepatocellular carcinoma.